Skip to content

LITS

Lite Strategy, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.16
+0.87%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue———65.3M48.8M
Cost of Revenue——368.0K——
Gross Profit——(368.0K)65.3M48.8M
Operating Expenses
R&D Expense122.0K122.0K3.9M16.6M52.5M
SG&A Expense12.0M12.1M13.5M23.3M33.1M
General & Admin Expense6.4M—13.5M23.3M33.1M
Selling & Marketing Expense—————
Other Expenses631.0K—(368.0K)10.9M—
Total Operating Expenses12.8M12.3M17.1M50.8M85.6M
Cost and Expenses12.8M12.3M17.5M50.8M85.6M
Operating Income (EBIT)(12.8M)(12.3M)(17.5M)14.5M(36.8M)
Non-Operating
Interest Income267.0K267.0K1.0M3.3M3.3M
Interest Expense—————
Net Interest Income267.0K267.0K1.0M3.3M3.3M
Other Non-Op Income/Expense(58.4M)(58.9M)1.5M3.2M4.9M
Non-Operating Income (excl Interest)(631.0K)——(10.9M)—
EBT (Pre-Tax Income)(71.2M)(71.2M)(15.9M)17.8M(31.8M)
Income Tax Expense—————
Bottom Line
Net Income(71.2M)(71.2M)(15.9M)17.8M(31.8M)
Earnings from Cont. Ops(71.2M)(71.2M)(15.9M)17.8M(31.8M)
Earnings from Discont. Ops—————
Bottom Line Net Income(71.2M)(71.2M)(15.9M)17.8M(31.8M)
Per Share
Basic EPS($9.11)($2.06)($2.39)$2.67($4.78)
Diluted EPS($9.11)($2.06)($2.39)$2.67($4.78)
Revenue Per Share$0.00$0.00$0.00$9.80$7.33
Shares
Basic Shares Outstanding34.6M34.6M6.7M6.7M6.7M
Diluted Shares Outstanding34.6M34.6M6.7M6.7M6.7M
Profitability Metrics
EBITDA(12.2M)(12.3M)(17.1M)25.8M(36.4M)
D&A——368.0K383.0K386.0K
EBIT(12.2M)(12.3M)(17.5M)25.4M(36.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026